CABA: Cabaletta Bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 57.19
Enterprise Value ($M) -106.78
Book Value ($M) 152.34
Book Value / Share 3.12
Price / Book 0.38
NCAV ($M) 133.96
NCAV / Share 2.74
Price / NCAV 0.43

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.52

Liquidity (mrq)
Quick Ratio 6.15
Current Ratio 6.15

Balance Sheet (mrq) ($M)
Current Assets 166.68
Assets 185.05
Liabilities 32.71
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -125.14
Net Income -115.86

Cash Flow Statement (mra) ($M)
Cash From Operations -88.22
Cash from Investing 47.29
Cash from Financing 11.68

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-05 13G/A BlackRock, Inc. 7.00 -22.95
12-06 13G/A Alger Associates Inc 2.70 -67.81
12-05 13G/A Jennison Associates Llc 5.10 -51.41
12-05 13G/A Prudential Financial Inc 5.70 -50.51
11-14 13G/A Venrock Healthcare Capital Partners III, L.P. 3.30 -37.96
11-14 13G T. Rowe Price Investment Management, Inc. 7.50
11-12 13G/A Adage Capital Management, L.P. 7.43
11-12 13G/A Vanguard Group Inc 5.22 0.00
10-17 13G/A State Street Corp 1.80 -65.46
08-22 13G Bain Capital Life Sciences Opportunities III, LP 5.70 38.04

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 426,109 1,291,955 32.98
2025-04-01 604,340 1,606,810 37.61
2025-03-31 439,902 1,466,187 30.00
2025-03-28 151,948 508,105 29.90

(click for more detail)

Similar Companies
BMEA – Biomea Fusion, Inc. BMRN – BioMarin Pharmaceutical Inc.
BPMC – Blueprint Medicines Corporation CCCC – C4 Therapeutics, Inc.
CGC – Canopy Growth Corporation


Financial data and stock pages provided by
Fintel.io